Mast Group Ltd
Alex D'Ambrogio is a Chartered MCIPD HR professional with extensive experience in various HR roles across multiple organizations. Currently serving as HR Manager at Mast Group Ltd since October 2022, Alex previously held positions including UK HR Manager at HellermannTyton United Kingdom, and Regional HR Manager at Bouygues E&S Solutions Ltd, where strategic guidance was provided for staff at different levels. Experience also includes HR Manager roles at Iron Mountain and Lookers PLC, where employee relations, organizational change, and coaching were key responsibilities. Earlier roles span HR functions at PayPoint.net, T Mobile UK Retail, VolkerFitzpatrick Ltd, and the Crown Prosecution Service, starting with a stand-alone HR Officer position at Johnson Matthey. Alex holds a Bachelor's Degree in Psychology from Glyndwr University.
This person is not in any teams
This person is not in any offices
Mast Group Ltd
1 followers
Mast Group Ltd is a UK based leading independent European manufacturer and supplier of clinical diagnostic products. Established in Liverpool in 1957, Mast Group has grown into a multinational company exporting globally. The corporate headquarters Mast Group Ltd are based in Bootle and has subsidiary companies in Reinfeld (Mast Diagnostica GmbH) and Amiens, France (Mast Diagnostic). Mast Group were among the first companies to commercialise the antibiotic disc, and continue to work with major pharmaceutical companies worldwide in the development of new and exciting products. Mast Group focuses on the susceptibility, identification and resistance along with offering molecular and immunochemistry solutions for the IVD market. This is achieved through the investment in personnel, R&D and infrastructure, including state of the art manufacturing facilities in Merseyside. This enables Mast Group to provide tools to aid in the diagnosis of clinical disease, from pioneering antibiotic susceptibility testing to novel molecular solutions, Mast Group continues to develop products for the ever changing IVD market, creating solutions to support clinical diagnosis today and into the future.